researchers are exploring the use of circular single-stranded dna and other nucleic acids, such as circular rna, as a potential approach for cancer vaccines. this approach is part of a broader effort to develop innovative vaccine strategies, including the use of lipid nanoparticles and personalized neoantigen therapies. the development of these technologies is ongoing, with various studies and reviews discussing their therapeutic prospects and potential applications in treating different types of cancer.